Mariner Investment Group’s Biogen BIIB Stock Holding History

Mariner Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,682	Closed	-$1.86M	–	90
2016 Q2	$1.86M	Sell	7,682 -11,000	-59%	-$2.9M	0.63%	46
2016 Q1	$4.86M	Buy	18,682 +5,000	+37%	+$1.32M	1.34%	25
2015 Q4	$4.19M	Sell	13,682 -16,400	-55%	-$4.71M	0.93%	34
2015 Q3	$8.78M	Buy	30,082 +20,643	+219%	+$6.82M	1.77%	10
2015 Q2	$3.81M	Buy	9,439 +5,400	+134%	+$2.17M	0.97%	34
2015 Q1	$1.71M	Sell	4,039 -16,500	-80%	-$6.5M	0.46%	74
2014 Q4	$6.97M	Buy	20,539 +6,800	+49%	+$2.2M	1.19%	13
2014 Q3	$4.54M	Buy	13,739 +9,739	+243%	+$3.21M	0.94%	22
2014 Q2	$1.26M	Buy	+4,000	New	+$1.2M	0.24%	99

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mariner Investment Group's BIIB Position: Q3 2016 in Review

Mariner Investment Group sold out of Biogen (BIIB) in Q3 2016, closing a stake of 7,682 shares — an estimated $1.86M sold.

Mariner Investment Group first reported a position in BIIB in Q2 2014 and held it in 9 quarters. The position peaked at $8.78M in Q3 2015. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

Mariner Investment Group reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 7,682 Biogen shares in Q3 2016, an estimated $1.86M.
Mariner Investment Group first reported a position in Biogen in Q2 2014 and held it in 9 quarters.
Mariner Investment Group's Biogen position peaked at $8.78M in Q3 2015.
1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.